Regulatory PathRegulatory requirements compared

Active substances

Ezetimibe + Simvastatin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
INEGY20,10 mg,mgTablet · Oral use28 BlisterSAR 119.40NCE · PrescriptionOrganon Pharma UK LimitedValid
INEGY40,10 mg,mgTablet · Oral use28 BlisterSAR 135.75NCE · PrescriptionOrganon Pharma UK LimitedValid
LUNIA10,40 mg,mgTablet · Oral use28 BlisterSAR 156.55Generic · PrescriptionALPHA PHARMA INDUSTRYValid
LUNIA10,20 mg,mgTablet · Oral use28 BlisterSAR 134.20Generic · PrescriptionALPHA PHARMA INDUSTRYValid
Simvagen Plus10,20 mg,mgTablet · Oral use30 BlisterSAR 133.50Generic · PrescriptionRIYADH PHARMAValid
Simvagen Plus10,40 mg,mgTablet · Oral use30 BlisterSAR 155.75Generic · PrescriptionRIYADH PHARMAValid
INEGY 20-10MG TABLETS20, 10 mgTablet · Oral use28 BlisterSAR 273.40NCE · PrescriptionMERCK SHARP & DOHMEWithdrawn by MAH · Not Marketed
INEGY 40-10MG TABLET40, 10 mgTablet · Oral use28 BlisterSAR 296.70NCE · PrescriptionMERCK SHARP & DOHMEWithdrawn by MAH · Not Marketed
INEGY 80-10MG TABLETS80, 10 mgTablet · Oral use28 BlisterSAR 251.70NCE · PrescriptionMERCK SHARP & DOHMEWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

CORONARY ARTERY DISEASE; DYSLIPIDEMIA

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
VYTORIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralORGANONPrescription23 Jul 2004
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralDR REDDYS LABS SAPrescription26 Apr 2017
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralALKEM LABS LTDPrescription22 Dec 2017
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralGLENMARK PHARMS LTDPrescription27 Jun 2019
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralAUROBINDO PHARMA USAPrescription17 Dec 2020
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralANI PHARMSDiscontinued26 Apr 2017
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralWATSON LABS INCDiscontinued26 Apr 2017
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralAMNEAL PHARMS CODiscontinued21 Nov 2017
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralSCIEGEN PHARMSDiscontinued10 Dec 2024
EZETIMIBE AND SIMVASTATIN10MG;10MG; 10MG;20MG; 10MG;40MG; 10MG;80MGtablet · oralTORRENTDiscontinued27 Jan 2025

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACEZETIMIBE-SIMVASTATIN 10-10 MG$0.27376per EA23 Sep 2026
US NADACEZETIMIBE-SIMVASTATIN 10-20 MG$0.1985per EA23 Sep 2026
US NADACEZETIMIBE-SIMVASTATIN 10-40 MG$0.18305per EA23 Sep 2026
US NADACEZETIMIBE-SIMVASTATIN 10-80 MG$0.28477per EA23 Sep 2026
US NADACVYTORIN 10-20 MG TABLET$13.6206per EA23 Sep 2026
US NADACVYTORIN 10-40 MG TABLET$13.79507per EA23 Sep 2026
NHS Drug TariffSimvastatin 20mg / Ezetimibe 10mg tablets£33.4228 tablet1 Oct 2026
NHS Drug TariffSimvastatin 40mg / Ezetimibe 10mg tablets£38.9828 tablet1 Oct 2026
NHS Drug TariffSimvastatin 80mg / Ezetimibe 10mg tablets£41.2128 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.